The exine coatings of spores can be used to encapsulate drug molecules. We have demonstrated that these microcapsules can be filled with a commercial gadolinium(III) MRI contrast agent (in this proof of concept study Gd–DTPA–BMA was used) which is slowly released in plasma due to enzymatic digestion of the capsule.